Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase II a open‐label trial and subsequent phase III open‐label extension
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase
II
a open‐label trial and subsequent phase
III
open‐label extension
Authors
Keywords
-
Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-09
DOI
10.1111/bjd.18476
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of dupilimab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis
- (2019) Elaine C. Siegfried et al. PEDIATRIC DERMATOLOGY
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
- (2018) M. de Bruin-Weller et al. BRITISH JOURNAL OF DERMATOLOGY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term off-label dupilumab in pediatric atopic dermatitis: A case series
- (2018) Alison D. Treister et al. PEDIATRIC DERMATOLOGY
- Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey
- (2017) Christine R. Totri et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
- (2016) Claus Bachert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
- (2016) Diamant Thaçi et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Study of the Atopic March: Development of Atopic Comorbidities
- (2016) Lynda Schneider et al. PEDIATRIC DERMATOLOGY
- Suicidal Ideation, Mental Health Problems, and Social Function in Adolescents with Eczema: A Population-Based Study
- (2014) Jon A. Halvorsen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe Eczema in Infancy Can Predict Asthma Development. A Prospective Study to the Age of 10 Years
- (2014) Marie Ekbäck et al. PLoS One
- Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
- (2014) L. E. Macdonald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
- (2014) A. J. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The European treatment of severe atopic eczema in children taskforce (TREAT) survey
- (2013) L.E. Proudfoot et al. BRITISH JOURNAL OF DERMATOLOGY
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis
- (2011) Marcia J. Slattery et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health
- (2010) Tatyana E. Shaw et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three
- (2009) Joseph A. Odhiambo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Childhood eczema and asthma incidence and persistence: A cohort study from childhood to middle age
- (2008) John A. Burgess et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started